Evidence map›Paper›PMID 34522845›Full record

ArticleHemaSphere2021

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders.

Sabine Eichinger, Pierre E Morange, Marco Cattaneo, Mathilde Fretigny, Antoine Rauch, Astrid van Hylckama Vlieg, David-Alexandre Trégouët, Wolfram Ruf, Marcel Levi, José A Páramo and 4 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sabine EichingerDepartment of Medicine I, Division of Hematology and Hemostasis, Medical University of Vienna, Austria.
Pierre E MorangeC2VN, INRAE, INSERM Aix-Marseille University, France.
Marco CattaneoUniversità degli Studi di Milano, Italy.
Mathilde FretignyHospices Civils de Lyon, France.
Antoine RauchUniversity of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, France.
Astrid van Hylckama VliegDepartment of Clinical Epidemiology, Leiden University Medical Center, The Netherlands.
David-Alexandre TrégouëtUniversity Bordeaux, INSERM UMR 1219, Bordeaux Population Health Research Center, France.
Wolfram RufCenter for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany.
Marcel LeviAmsterdam University Medical Centers, Department of Vascular Medicine, University of Amsterdam, The Netherlands.
José A PáramoClínica Universidad de Navarra, Pamplona, Spain.
Tom van der PollAmsterdam University Medical Centers, Division of Infectious Diseases & Center of Experimental Molecular Medicine, University of Amsterdam, The Netherlands.
Paul A KyrleDepartment of Medicine I, Division of Hematology and Hemostasis, Medical University of Vienna, Austria.
Isabella GaragiolaFondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy.
Flora PeyvandiFondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34522845
PMCPMC8432639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.